News

Home > News & Events > Medial EarlySign Analyzes Blood Tests with Artificial Intelligence

Medial EarlySign Analyzes Blood Tests with Artificial Intelligence

Medial EarlySign Analyzes Blood Tests with Artificial Intelligence


June 28, 2017

 

Israeli-start-up Medial EarlySign is successfully applying Machine Learning algorithms to ordinary blood test results and existing EMR data to identify pateitns at high risk of harboring life-threatening diseases. In May, the venture has been recognized as one of Gartner’s Cool Vendors in AI for Healthcare.

 

I asked Tomer Amit, VP of Corporate Marketing, about EarlySign’s work and achievements.

 

View the full Q&A here.